Evidence map›Paper›PMID 36333395›Full record

ArticleScientific reports2022

Grafting of short elastin-like peptides using an electric field.

Nuttanit Pramounmat, Sogol Asaei, Jacob D Hostert, Kathleen Young, Horst A von Recum, Julie N Renner

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nuttanit PramounmatDepartment of Chemical and Biomolecular Engineering, Case Western Reserve University, Cleveland, USA.
Sogol Asaei *Department of Chemical and Biomolecular Engineering, Case Western Reserve University, Cleveland, USA.
Jacob D Hostert *Department of Chemical and Biomolecular Engineering, Case Western Reserve University, Cleveland, USA.
Kathleen Young
Horst A von RecumDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, USA.
Julie N RennerDepartment of Chemical and Biomolecular Engineering, Case Western Reserve University, Cleveland, USA. julie.renner@case.edu.

Funding

National Science Foundation 2045033United States Department of Agriculture 2018-68011-28691
6 · The paper itself

Abstract

Surface-grafted elastin has found a wide range of uses such as sensing, tissue engineering and capture/release applications because of its ability to undergo stimuli-responsive phase transition. While various methods exist to control surface grafting in general, it is still difficult to control orientation as attachment occurs. This study investigates using an electric field as a new approach to control the surface-grafting of short elastin-like polypeptide (ELP). Characterization of ELP grafting to gold via quartz crystal microbalance with dissipation, atomic force microscopy and temperature ramping experiments revealed that the charge/hydrophobicity of the peptides, rearrangement kinetics and an applied electric field impacted the grafted morphology of ELP. Specifically, an ELP with a negative charge on the opposite end of the surface-binding moiety assembled in a more upright orientation, and a sufficient electric field pushed the charge away from the surface compared to when the same peptide was assembled in no electric field. In addition, this study demonstrated that assembling charged ELP in an applied electric field impacts transition behavior. Overall, this study reveals new strategies for achieving desirable and predictable surface properties of surface-bound ELP.

Indexed as

ElastinPeptidesHydrophobic and Hydrophilic InteractionsPhase TransitionSurface PropertiesElastinPeptides

Identifiers

PMID36333395
PMCPMC9636273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.